Director & President, R&D
Director & President, R&D at Krystal Biotech, Inc., filing insider transactions between 2026-03-04 and 2026-06-04.
| SEC ↗ |
| 2026-06-04 | KRYS | Sale | 2,039 | $310.94 | $634K | SEC ↗ |
| 2026-06-04 | KRYS | Sale | 240 | $311.65 | $75K | SEC ↗ |
| 2026-06-04 | KRYS | Sale | 247 | $303.17 | $75K | SEC ↗ |
| 2026-06-04 | KRYS | Sale | 2,801 | $309.95 | $868K | SEC ↗ |
| 2026-06-04 | KRYS | Sale | 320 | $300.75 | $96K | SEC ↗ |
| 2026-06-04 | KRYS | Sale | 3,803 | $308.89 | $1.2M | SEC ↗ |
| 2026-06-04 | KRYS | Sale | 400 | $304.89 | $122K | SEC ↗ |
| 2026-06-04 | KRYS | Sale | 480 | $305.87 | $147K | SEC ↗ |
| 2026-03-04 | KRYS | Sale | 1,938 | $262.35 | $508K | SEC ↗ |
| 2026-03-04 | KRYS | Sale | 2,248 | $263.58 | $593K | SEC ↗ |
| 2026-03-04 | KRYS | Sale | 2,931 | $261.41 | $766K | SEC ↗ |
| 2026-03-04 | KRYS | Sale | 3,667 | $260.37 | $955K | SEC ↗ |
| 2026-03-04 | KRYS | Sale | 407 | $257.32 | $105K | SEC ↗ |
| 2026-03-04 | KRYS | Sale | 4,852 | $264.64 | $1.3M | SEC ↗ |
| 2026-03-04 | KRYS | Sale | 589 | $258.54 | $152K | SEC ↗ |
| 2026-03-04 | KRYS | Sale | 6,000 | $265.16 | $1.6M | SEC ↗ |
| 2026-03-04 | KRYS | Sale | 668 | $259.61 | $173K | SEC ↗ |
| 2026-03-04 | KRYS | Sale | 1,700 | $266.42 | $453K | SEC ↗ |